RECURSION PHARMACEUTICALS, INC. (RXRX) › Shareholders' EquityRECURSION PHARMACEUTICALS, INC. (RXRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$63.85M2019: -$124.27M2020: -$206.29M2021: $542.94M2022: $485.81M2023: $463.44M2024: $1.03B2025: $1.13B$1.13B2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.13B+9.3%2024$1.03B+123.3%2023$463.44M-4.6%2022$485.81M-10.5%2021$542.94M+363.2%2020-$206.29M-66.0%2019-$124.27M-94.6%2018-$63.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share